MMP19 antibody - Carboxyterminal end (ab39029)

Product Name 

MMP19 antibody - Carboxyterminal end

Product type 

Primary antibodies

Description 

Rabbit polyclonal to MMP19 - Carboxyterminal end

Immunogen 

Synthetic peptide corresponding to the carboxyterminal end of human MMP19.

Reacts with 
(species key)

Hu

Specificity 

ab39029 recognises the Carboxyterminal end of MMP19. It does not recognise the smallest active form of MMP19 as the hemopexin domain is cleaved from it.
This antibody will bind to the reduced and non reduced form of MMP19, but does not cross react with the other MMP family members (MMP1, MMP2, MMP3, MMP9, etc.)

We have a range of domain specific antibodies for this target. For a full list please see all MMP19 antibodies

Tested applications 
(see key)

WB

Abreviews 

Customer reviews (see key)

Read about Abreviews

Application notes 
(see key)

Recommended dilutions
WB: 1/1000 when using colorimetric substrates such as BCIP/NBT - 1/5000 when using chemiluminescent substrates. Predicted molecular weight: 57 kDa. When used against the reduced protein, ab39029 identifies bands at 58 Kd, 45 Kd, and a series of further cleaved active forms. Note: the conditioned media may need to be concentrated for Western blot. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Cellular localization 

Secreted

Research areas 

Cancer >> Tumor biomarkers >> Enzymes >> MMPs
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> MMPs
Cancer >> Invasion/microenvironment >> Angiogenesis >> ECM enzymes >> MMPs
Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP

Relevance 

Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development,reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. MMP19 is one of the more recently identified MMPs, has several novel structural features, and so does not fall into the traditional MMP groupings. It is without a furin cleavage site or transmembrane domain and unlike the other MMPs, MMP19 has an 8-residue acidic patch at the beginning of the hinge region. MMP19 is not constituitively produced by most cell types; it has been found in lung fibroblasts, and gingival fibroblasts when stimulated with TPA, as well as breast tumor and osteosarcoma cell lines. MMP19 may play a role in pathological processes participating in rheumatoid arthritis (RA)-associated joint tissue destruction. Autoantigens to anti-MMP19 are frequent in RA patients.

Database links 

Raised in 

Rabbit

Clonality 

Polyclonal

Isotype 

IgG

Purity 

Immunogen affinity purified

Storage buffer 

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol, PBS

Material safety datasheets (MSDS) for this product:
Glycerol MSDS
Sodium Azide MSDS

Form 

Liquid

Concentration 

1.000 mg/ml

Storage instructions 

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Customer reviews (feedback) regarding MMP19 antibody - Carboxyterminal end

Customer FAQs regarding MMP19 antibody - Carboxyterminal end

Protocols for MMP19 antibody - Carboxyterminal end

Price and availability of products related to MMP19 antibody - Carboxyterminal end

MMP19 antibody - Carboxyterminal end - related products: